The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. Clin Interv Aging. 2015;10:1421–1429.On page 1423, Figure 2 Citicoline’s metabolic pathways, please note that this figure has been modified to include: Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicolin...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2015
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/7dae5f0708694c12a78b84b1504d1d15 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|